辅助性T淋巴细胞22及其效应因子IL-22在自身免疫性肝炎小鼠模型中的表达及意义

潘景; 潘文婷; 吴丽慧

doi:10.3969/j.issn.1001-5256.2018.08.030

辅助性T淋巴细胞22及其效应因子IL-22在自身免疫性肝炎小鼠模型中的表达及意义

DOI: 10.3969/j.issn.1001-5256.2018.08.030

1. 温州医科大学附属第二医院
2. 温州医科大学

基金项目:

国家自然科学基金(H0923;H0929)；

详细信息

中图分类号: R-332;R575.1
计量
- 文章访问数: 1913
- HTML全文浏览量: 33
- PDF下载量: 393
- 被引次数: 0
出版历程
- 收稿日期: 2018-03-03
- 出版日期: 2018-08-20

Expression and significance of Th22 cells and its functional factor interleukin-22 in mice with autoimmune hepatitis

The Second Affiliated Hospital of Wenzhou Medical University

Research funding:

摘要

摘要:
目的研究自身免疫性肝炎（AIH）小鼠模型中辅助性T淋巴细胞（Th）22细胞水平及其功能因子IL-22的表达情况,探索其在AIH发病中的意义。方法选取30只4周龄雄性C57BL/6小鼠随机分为对照组（n=6）、AIH组（n=14）,剩余10只用于提取肝脏特异性抗原S100。在实验第1天和第7天通过腹腔注射法将新鲜提取的S100与等体积弗氏完全佐剂混合液注射到小鼠腹腔内,第28天成功建立AIH小鼠模型（造模期间AIH组有7只小鼠因注射不当、出现腹水、感染等原因死亡）后,将小鼠经腹腔注射5%水合氯醛（0.1 ml/10 g）麻醉后摘取眼球取血,收集小鼠脾脏采用流式细胞术检测Th22细胞数,RT-PCR检测AHR mRNA水平;收集肝组织用于HE染色观察肝脏病理变化,RT-PCR和免疫印迹法检测肝组织IL-22、IL-22R表达情况;ELISA法检测血清中IL-22细胞因子水平。2组间比较采用t检验。结果对照组小鼠肝组织排列整齐,肝小叶结构清晰,AIH组小鼠汇管区有大量炎症细胞浸润,肝组织出现点状甚至碎片状坏死。AIH组Th22细胞数较对照组明显升高[（0.083±0.052）%vs（1.55...
- 肝炎,自身免疫性 /
- T淋巴细胞,辅助诱导 /
- 白细胞介素22 /
- 小鼠,近交C57BL
Abstract:
Objective To investigate the expression of Th22 cells and its functional factor interleukin-22 ( IL-22) in a mouse model of autoimmune hepatitis ( AIH) and the significance of Th22 cells and IL-22 in the pathogenesis of AIH. Methods A total of 30 male C57 BL/6 mice aged 4 weeks were randomly divided into control group with 6 mice and AIH group with 14 mice. Another 10 mice were used to extract liver-specific antigen S100. On days 1 and 7 of the experiment, the freshly extracted S100 was injected into the abdominal cavity of the mice together with an equal volume of Freund's complete adjuvant, and a mouse model of AIH was successfully established on day 28 ( 7 mice in the AIH group died during model establishment due to improper injection, presence of ascites, or infection) . The mice were given intraperitoneal injection of 5% chloral hydrate ( 0. 1 ml/10 g) for anesthesia, and then eyeballs were removed to collect blood samples.The spleen was collected, and flow cytometry was performed to measure the percentage of Th22 cells and RT-PCR was performed to measure the mRNA expression of aryl hydrocarbon receptor ( AHR) . The liver tissue was collected; HE staining was used to observe liver pathological changes, and RT-PCR and Western blotting were used to measure the expression of IL-22 and IL-22 receptor ( IL-22 R) in liver tissue. ELISA was used to measure the serum level of IL-22. The t-test was used for comparison between the two groups. Results HE staining showed that the mice in the control group had well-arranged liver tissue and clear structures of hepatic lobules, while those in the AIH group had massive inflammatory cell infiltration in the portal area and dotted and even piecemeal necrosis in liver tissue. The AIH group had a significant increase in the percentage of Th22 cells than the control group ( 0. 083% ± 0. 052% vs 1. 555% ± 0. 812%, t =-4. 405, P < 0. 05) . Compared with the control group, the AIH group had a significant increase in the relative mRNA expression of AHR ( 0. 485 ±0. 096 vs 1. 268 ± 0. 366, t =-5. 452, P < 0. 05) . Compared with the control group, the AIH group had significant increases in the relative mRNA expression of IL-22 ( 1. 146 ± 0. 227 vs 3. 813 ± 0. 478, t =-12. 458, P < 0. 001) and IL-22 R ( 0. 276 ± 0. 037 vs 1. 734 ±0. 248, t =-15. 333, P < 0. 001) and significantly higher relative protein expression of IL-22 ( 1. 040 ± 0. 261 vs 0. 410 ± 0. 077, t =-6. 324, P < 0. 05) and IL-22 R ( 1. 432 ± 0. 304 vs 0. 830 ± 0. 146, t =-0. 631, P < 0. 05) in liver tissue. The AIH group had a significantly higher level of IL-22 than the control group ( t =-15. 799, P < 0. 05) . Conclusion AIH mice have significant increases in the percentage of Th22 cells and the expression of IL-22, which may play an important role in the pathogenesis of AIH.
- hepatitis, autoimmune /
- T-lymphocytes, helper-inducer /
- interleukin-23 /
- mice, inbred C57BL

HTML全文

参考文献(18)

[1]MAKOL A, WATT KD, CHOWDHARY VR.Autoimmune hepatitis:A review of current diagnosis and treatment[J].Hepat Res Treat, 2011, 2011:390916.

[2]HENEGHAN MA, YEOMAN AD, VERMA S, et al.Autoimmune hepatitis[J].J Lancet, 2013, 382 (9902) :1433-1444.

[3]CZAJA AJ.Autoimmune hepatitis in diverse ethnic populations and geographical regions[J].Expert Rev Gastroenterol Hepatol, 2013, 7 (4) :365-385.

[4]ABDOLLAHI MR, SOMI MH, FARAJI E.Role of international criteria in the diagnosis of autoimmune hepatitis[J].World J Gastroenterol, 2013, 19 (23) :3629-3633.

[5]MANNS MP, LOHSE AW, VERGANI D.Autoimmune hepatitis——Update 2015[J].J Hepatol, 2015, 62 (1 Suppl) :s100-s111.

[6]HONDA K.IL-22 from T cells:Better late than never[J].Immunity, 2012, 37 (6) :952-954.

[7]ROLLA S, BARDINA V, de MERCANTI S, et al.Th22 cells are expanded in multiple sclerosis and are resistant to IFN-beta[J].J Leukoc Biol, 2014, 96 (6) :1155-1164.

[8]BENHAM H, NORRIS P, GOODALL J, et al.Th17 and Th22cells in psoriatic arthritis and psoriasis[J].Arthritis Res Ther, 2013, 15 (5) :r136.

[9]LUAN L, DING Y, HAN S, et al.An increased proportion of circulating Th22 and Tc22 cells in psoriasis[J].Cell Immunol, 2014, 290 (2) :196-200.

[10]SONNENBERG GF, FOUSER LA, ARTIS D.Functional biology of the IL-22-IL-22R pathway in regulating immunity and inflammation at barrier surfaces[J].Adv Immunol, 2010, 107:1-29.

[11]YANG X, ZHENG SG.Interleukin-22:A likely target for treatment of autoimmune diseases[J].Autoimmun Rev, 2014, 13 (6) :615-620.

[12]LONGHI MS, MA Y, MIELI-VERGANI G, et al.Aetiopathogenesis of autoimmunehepatitis[J].J Autoimmun, 2010, 34 (1) :7-14.

[13]LIBERAL R, GRANT CR, LONGHI MS, et al.Regulatory T cells:Mechanisms of suppression and impairment in autoimmune liver disease[J].Iubmb Life, 2015, 67 (2) :88-97.

[14]SEBODE M, LOHSE AW.Future perspective:Immunomodulatory therapy for autoimmune hepatitis[J].Dig Dis, 2014, 32 (5) :502-506.

[15]ZHANG L, LI YG, LI YH, et al.Increased frequencies of Th22 cells as well as Th17 cells in the peripheral blood of patients with ankylosing spondylitis and rheumatoid arthritis[J].Plos One, 2012, 7 (4) :e31000.

[16]KAGAMI S, RIZZO HL, LEE JJ, et al.Circulating Th17, Th22, and Th1 cells are increased in psoriasis[J].J Invest Dermatol, 2010, 130 (5) :1373-1383.

[17]ZHAO L, JIANG ZY, JIANG YF, et al.IL-22 (+) CD4 (+) T-cells in patients with active systemic lupus erythematosus[J].Exp Biol M, 2013, 238 (2) :193-199.

[18]KAWATA K, TSUDA M, YANG GX, et al.Identification of potential cytokine pathways for therapeutic intervention in murine primary biliary cirrhosis[J].PLo S One, 2013, 8 (9) :e74225.

施引文献

资源附件(0)

访问统计